Literature DB >> 11129815

Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis.

T Ohkubo1, J Yamamoto, Y Sugawara, K Shimada, S Yamasaki, M Makuuchi, T Kosuge.   

Abstract

BACKGROUND: The longterm results after liver resection for hepatocellular carcinoma with macroscopic tumor thrombus of the portal vein are unclear. STUDY
DESIGN: The records of 47 HCC patients with tumor thrombus in the segmental portal branch (n = 33) and the first portal branch or portal vein trunk (n = 14) were reviewed in this study. Survival rates of the patients were calculated with regard to 14 dinicopathologic variables. A log-rank analysis was performed to identify which variables predicted the prognosis.
RESULTS: Overall 1-, 3-, and 5-year survival rates were 53.9%, 33.2%, and 23.9%, respectively. The indicators of a favorable prognosis included curative liver resection, tumor size less than 10 cm in diameter, and absence of intrahepatic metastases.
CONCLUSIONS: Liver resection should be considered a therapeutic option for hepatocellular carcinoma with macroscopic portal vein tumor thrombus when the tumor is small and curative liver resection can be expected.

Entities:  

Mesh:

Year:  2000        PMID: 11129815     DOI: 10.1016/s1072-7515(00)00740-7

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  34 in total

1.  Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jia Fan; Jian Zhou; Zhi-Quan Wu; Shuang-Jian Qiu; Xiao-Ying Wang; Ying-Hong Shi; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

Review 2.  Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus.

Authors:  Masami Minagawa; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 3.  Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016.

Authors:  Stephen L Chan; Charing C N Chong; Anthony W H Chan; Darren M C Poon; Kenneth S H Chok
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

4.  Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis--a randomized study.

Authors:  Q Li; J Wang; Y Sun; Y L Cui; J T Juzi; H X Li; B Y Qian; X S Hao
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

5.  The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.

Authors:  Xu-Biao Wei; Jie Xu; Nan Li; Ying Yu; Jie Shi; Wei-Xing Guo; Hong-Yan Cheng; Meng-Chao Wu; Wan-Yee Lau; Shu-Qun Cheng
Journal:  HPB (Oxford)       Date:  2015-11-17       Impact factor: 3.647

6.  High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection.

Authors:  Li-Shuai Qu; Fei Jin; Xiao-Wu Huang; Xi-Zhong Shen
Journal:  J Gastrointest Surg       Date:  2010-04-27       Impact factor: 3.452

Review 7.  Recent advances in the surgical treatment of hepatocellular carcinoma.

Authors:  Zenichi Morise; Norihiko Kawabe; Hirokazu Tomishige; Hidetoshi Nagata; Jin Kawase; Satoshi Arakawa; Rie Yoshida; Masashi Isetani
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

8.  New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.

Authors:  Takumi Fukumoto; Masahiro Kido; Atsushi Takebe; Motofumi Tanaka; Hisoka Kinoshita; Kaori Kuramitsu; Shohei Komatsu; Daisuke Tsugawa; Tadahiro Goto; Sadaki Asari; Hirochika Toyama; Tetsuo Ajiki; Yonson Ku
Journal:  Surg Today       Date:  2017-03-21       Impact factor: 2.549

9.  Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma.

Authors:  Toshiya Kamiyama; Kazuaki Nakanishi; Hideki Yokoo; Munenori Tahara; Takahito Nakagawa; Hirofumi Kamachi; Hiroshi Taguchi; Hiroki Shirato; Michiaki Matsushita; Satoru Todo
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

10.  A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.

Authors:  Chong Zhong; Rong-ping Guo; Jin-qing Li; Ming Shi; Wei Wei; Min-shan Chen; Ya-qi Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-01       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.